Endosense Launches TactiCath® 75 Force-Sensing Catheter, Announces New Results of EFFICAS I Clinical Study

GENEVA--(BUSINESS WIRE)--Endosense, a pioneer and leader in force-sensing technology focused on improving the efficacy and safety of catheter ablation for the treatment of cardiac arrhythmias, has announced the European launch of the TactiCath 75 force-sensing ablation catheter as well as results of the EFFICAS clinical study of contact force-sensing in catheter ablation procedures.
MORE ON THIS TOPIC